These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11796823)

  • 1. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats.
    Hoshi S; Shu Y; Yoshida F; Inagaki T; Sonoda J; Watanabe T; Nomoto K; Nagata M
    Lab Invest; 2002 Jan; 82(1):25-35. PubMed ID: 11796823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early events leading to renal injury in obese Zucker (fatty) rats with type II diabetes.
    Coimbra TM; Janssen U; Gröne HJ; Ostendorf T; Kunter U; Schmidt H; Brabant G; Floege J
    Kidney Int; 2000 Jan; 57(1):167-82. PubMed ID: 10620198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of high glucose and TGF-beta1 on the expression of collagen IV and vascular endothelial growth factor in mouse podocytes.
    Iglesias-de la Cruz MC; Ziyadeh FN; Isono M; Kouahou M; Han DC; Kalluri R; Mundel P; Chen S
    Kidney Int; 2002 Sep; 62(3):901-13. PubMed ID: 12164872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diabetic kidney lesions of GIPRdn transgenic mice: podocyte hypertrophy and thickening of the GBM precede glomerular hypertrophy and glomerulosclerosis.
    Herbach N; Schairer I; Blutke A; Kautz S; Siebert A; Göke B; Wolf E; Wanke R
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F819-29. PubMed ID: 19211686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p27(Kip1) Knockout mice are protected from diabetic nephropathy: evidence for p27(Kip1) haplotype insufficiency.
    Wolf G; Schanze A; Stahl RA; Shankland SJ; Amann K
    Kidney Int; 2005 Oct; 68(4):1583-9. PubMed ID: 16164635
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Podocyte injury underlies the progression of focal segmental glomerulosclerosis in the fa/fa Zucker rat.
    Gassler N; Elger M; Kränzlin B; Kriz W; Gretz N; Hähnel B; Hosser H; Hartmann I
    Kidney Int; 2001 Jul; 60(1):106-16. PubMed ID: 11422742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Podocyte hypertrophic stress and detachment precedes hyperglycemia or albuminuria in a rat model of obesity and type2 diabetes-associated nephropathy.
    Minakawa A; Fukuda A; Sato Y; Kikuchi M; Kitamura K; Wiggins RC; Fujimoto S
    Sci Rep; 2019 Dec; 9(1):18485. PubMed ID: 31811176
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Podocyte-specific overexpression of GLUT1 surprisingly reduces mesangial matrix expansion in diabetic nephropathy in mice.
    Zhang H; Schin M; Saha J; Burke K; Holzman LB; Filipiak W; Saunders T; Xiang M; Heilig CW; Brosius FC
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F91-8. PubMed ID: 20375116
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasopeptidase inhibition attenuates proteinuria and podocyte injury in Zucker diabetic fatty rats.
    Fredersdorf S; Weil J; Ulucan C; Birner C; Büttner R; Schubert T; Böger CA; Debl K; Muders F; Riegger GA; Luchner A
    Naunyn Schmiedebergs Arch Pharmacol; 2007 Apr; 375(2):95-103. PubMed ID: 17333128
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin II receptor blocker inhibits p27Kip1 expression in glucose-stimulated podocytes and in diabetic glomeruli.
    Xu ZG; Yoo TH; Ryu DR; Cheon Park H; Ha SK; Han DS; Adler SG; Natarajan R; Kang SW
    Kidney Int; 2005 Mar; 67(3):944-52. PubMed ID: 15698433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with nebivolol attenuates renal damage in Zucker diabetic fatty rats.
    Toblli JE; Cao G; Giani JF; Muñoz MC; Angerosa M; Dominici FP
    J Hypertens; 2011 Aug; 29(8):1613-23. PubMed ID: 21720265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased glomerular cell (podocyte) apoptosis in rats with streptozotocin-induced diabetes mellitus: role in the development of diabetic glomerular disease.
    Menini S; Iacobini C; Oddi G; Ricci C; Simonelli P; Fallucca S; Grattarola M; Pugliese F; Pesce C; Pugliese G
    Diabetologia; 2007 Dec; 50(12):2591-9. PubMed ID: 17901943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPR43 deficiency protects against podocyte insulin resistance in diabetic nephropathy through the restoration of AMPKα activity.
    Lu J; Chen PP; Zhang JX; Li XQ; Wang GH; Yuan BY; Huang SJ; Liu XQ; Jiang TT; Wang MY; Liu WT; Ruan XZ; Liu BC; Ma KL
    Theranostics; 2021; 11(10):4728-4742. PubMed ID: 33754024
    [No Abstract]   [Full Text] [Related]  

  • 14. Potential role of angiotensin-converting enzyme inhibitors and statins on early podocyte damage in a model of type 2 diabetes mellitus, obesity, and mild hypertension.
    Blanco S; Vaquero M; Gómez-Guerrero C; López D; Egido J; Romero R
    Am J Hypertens; 2005 Apr; 18(4 Pt 1):557-65. PubMed ID: 15831368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vildagliptin restores renal myogenic function and attenuates renal sclerosis independently of effects on blood glucose or proteinuria in zucker diabetic fatty rat.
    Vavrinec P; Henning RH; Landheer SW; Wang Y; Deelman LE; Dokkum RP; Buikema H
    Curr Vasc Pharmacol; 2014; 12(6):836-44. PubMed ID: 24066937
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A neutralizing VEGF antibody prevents glomerular hypertrophy in a model of obese type 2 diabetes, the Zucker diabetic fatty rat.
    Schrijvers BF; Flyvbjerg A; Tilton RG; Lameire NH; De Vriese AS
    Nephrol Dial Transplant; 2006 Feb; 21(2):324-9. PubMed ID: 16249198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transgenic overexpression of GLUT1 in mouse glomeruli produces renal disease resembling diabetic glomerulosclerosis.
    Wang Y; Heilig K; Saunders T; Minto A; Deb DK; Chang A; Brosius F; Monteiro C; Heilig CW
    Am J Physiol Renal Physiol; 2010 Jul; 299(1):F99-F111. PubMed ID: 20375117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasopeptidase inhibition prevents nephropathy in Zucker diabetic fatty rats.
    Schäfer S; Linz W; Bube A; Gerl M; Huber J; Kürzel GU; Bleich M; Schmidts HL; Busch AE; Rütten H
    Cardiovasc Res; 2003 Nov; 60(2):447-54. PubMed ID: 14613875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.